These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37733767)

  • 1. Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Masrour M; Khanmohammadi S; Fallahtafti P; Rezaei N
    PLoS One; 2023; 18(9):e0291921. PubMed ID: 37733767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Hu Y; Guo G; Li J; Chen J; Tan P
    Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating diagnostic potential of long non-coding RNAs in head and neck squamous cell carcinoma using TCGA database and clinical specimens.
    Lan T; Yan Y; Zheng D; Ding L
    Sci Rep; 2024 Mar; 14(1):7500. PubMed ID: 38553620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
    Kang JW; Eun YG; Lee YC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
    Mao R; Chen Y; Xiong L; Liu Y; Zhang T
    Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ; Sun HH; Wang XT; Wang MT
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LINC01296 acts as a migration and invasion promoter in head and neck squamous cell carcinoma and predicts poor prognosis.
    Wu J; Chen H; Li J; Li X; Cao J; Qi M
    Bioengineered; 2021 Dec; 12(1):5607-5619. PubMed ID: 34515611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
    Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
    Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
    Chen L; Cai Z; Lyu K; Cai Z; Lei W
    Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2.
    Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
    Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.
    Wang J; Bian Q; Liu J; Moming A
    Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of long non-coding RNAs in head and neck squamous cell carcinoma.
    Ghafouri-Fard S; Mohammad-Rahimi H; Jazaeri M; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104353. PubMed ID: 31812485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
    Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.